Exact Mass: 377.107

Exact Mass Matches: 377.107

Found 35 metabolites which its exact mass value is equals to given mass value 377.107, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole

4-[4-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1H-imidazol-5-yl]pyridine

C21H16FN3OS (377.0998)


   

Maybridge1_000863

Maybridge1_000863

C21H16FN3OS (377.0998)


   

O1-(2-acetylamino-[1]naphthyl)-beta-D-glucopyranuronic acid|O1-(2-Acetylamino-[1]naphthyl)-beta-D-glucopyranuronsaeure

O1-(2-acetylamino-[1]naphthyl)-beta-D-glucopyranuronic acid|O1-(2-Acetylamino-[1]naphthyl)-beta-D-glucopyranuronsaeure

C18H19NO8 (377.1111)


   

4-methoxyfuro[2,3-b]quinolin-7-yl beta-D-mannopyranoside|dictamnine-7-beta-D-mannopyranoside

4-methoxyfuro[2,3-b]quinolin-7-yl beta-D-mannopyranoside|dictamnine-7-beta-D-mannopyranoside

C18H19NO8 (377.1111)


   

O1-(6-acetylamino-[2]naphthyl)-beta-D-glucopyranuronic acid|O1-(6-Acetylamino-[2]naphthyl)-beta-D-glucopyranuronsaeure

O1-(6-acetylamino-[2]naphthyl)-beta-D-glucopyranuronic acid|O1-(6-Acetylamino-[2]naphthyl)-beta-D-glucopyranuronsaeure

C18H19NO8 (377.1111)


   

Asp Asp Glu

Asp Asp Glu

C13H19N3O10 (377.107)


   

Glu Asp Asp

Glu Asp Asp

C13H19N3O10 (377.107)


   

SB 203580

4-[4-(4-fluorophenyl)-2-[4-methylsulfinyl)phenyl]-1H-imidazol-5-yl]-pyridine

C21H16FN3OS (377.0998)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents C308 - Immunotherapeutic Agent D004791 - Enzyme Inhibitors

   

Asp Glu Asp

Asp Glu Asp

C13H19N3O10 (377.107)


   

Asn-His-OH

(S)-2-(3-(2-amino-2-oxoethoxy)-4-nitrobenzamido)-4-(1H-imidazol-4-yl)butanoic acid

C15H15N5O7 (377.0971)


   

Omeprazole Sulfone N-Oxide

Omeprazole Sulfone N-Oxide

C17H19N3O5S (377.1045)


   

disperse blue 124

2-[N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino]ethyl acetate

C16H19N5O4S (377.1158)


   

Disperse Orange 29

Disperse Orange 29

C19H15N5O4 (377.1124)


   

2-Carboxy-5-fluoro-1-[(1-naphthalenyl)methyl]-1H-indole-3-acetic acid

2-Carboxy-5-fluoro-1-[(1-naphthalenyl)methyl]-1H-indole-3-acetic acid

C22H16FNO4 (377.1063)


   

2-BROMO-6-IODO-3-METHOXYPYRIDINE

2-BROMO-6-IODO-3-METHOXYPYRIDINE

C22H16FNO4 (377.1063)


   

tert-Butyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

tert-Butyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

C19H24BrNO2 (377.099)


   

Ronifibrate

3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl pyridine-3-carboxylate

C19H20ClNO5 (377.103)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates

   

ERRα antagonist-1

ERRα antagonist-1

C21H19N3S2 (377.102)


   

Selurampanel

Selurampanel

C16H19N5O4S (377.1158)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent

   

4-[[2-methoxy-4-[(4-nitrophenyl)azo]phenyl]azo]phenol

4-[[2-methoxy-4-[(4-nitrophenyl)azo]phenyl]azo]phenol

C19H15N5O4 (377.1124)


   

Pyridine, 4-(4-(4-fluorophenyl)-2-(5-((R)-methylsulfinyl)phenyl)-1H-imidazol-4-yl)-

Pyridine, 4-(4-(4-fluorophenyl)-2-(5-((R)-methylsulfinyl)phenyl)-1H-imidazol-4-yl)-

C21H16FN3OS (377.0998)


   

Acridine half-mustard

Acridine half-mustard

C19H21Cl2N3O (377.1062)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D009676 - Noxae > D009153 - Mutagens

   

[2-Amino-6-(2,6-difluoro-benzoyl)-imidazo[1,2-A]pyridin-3-YL]-phenyl-methanone

[2-Amino-6-(2,6-difluoro-benzoyl)-imidazo[1,2-A]pyridin-3-YL]-phenyl-methanone

C21H13F2N3O2 (377.0976)


   

Glu-Asp-Asp

Glu-Asp-Asp

C13H19N3O10 (377.107)


   

4-benzyl-N-(3,5-dichlorophenyl)-1,4-diazepane-1-carboxamide

4-benzyl-N-(3,5-dichlorophenyl)-1,4-diazepane-1-carboxamide

C19H21Cl2N3O (377.1062)


   

3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide

3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide

C20H15N3O5 (377.1012)


   

N-ethyl-8-methyl-4-oxo-N-(phenylmethyl)-2-thieno[3,2-c][1]benzopyrancarboxamide

N-ethyl-8-methyl-4-oxo-N-(phenylmethyl)-2-thieno[3,2-c][1]benzopyrancarboxamide

C22H19NO3S (377.1086)


   

2-[[2-Oxo-2-[4-[5-(trifluoromethyl)-2-pyridinyl]-1,4-diazepan-1-yl]ethyl]thio]acetic acid

2-[[2-Oxo-2-[4-[5-(trifluoromethyl)-2-pyridinyl]-1,4-diazepan-1-yl]ethyl]thio]acetic acid

C15H18F3N3O3S (377.1021)


   

Asp-Glu-Asp

Asp-Glu-Asp

C13H19N3O10 (377.107)


   

Asp-Asp-Glu

Asp-Asp-Glu

C13H19N3O10 (377.107)


   

(2S)-2-[[(2-chlorophenyl)-oxomethyl]amino]-3-methylbutanoic acid (3-cyano-4-imino-2-oxopentyl) ester

(2S)-2-[[(2-chlorophenyl)-oxomethyl]amino]-3-methylbutanoic acid (3-cyano-4-imino-2-oxopentyl) ester

C18H20ClN3O4 (377.1142)


   

n-(2-hydroxy-5-{[8-(hydroxymethyl)-3-oxophenoxazin-2-yl]amino}phenyl)carboximidic acid

n-(2-hydroxy-5-{[8-(hydroxymethyl)-3-oxophenoxazin-2-yl]amino}phenyl)carboximidic acid

C20H15N3O5 (377.1012)


   

2-(hydroxymethyl)-6-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)oxane-3,4,5-triol

2-(hydroxymethyl)-6-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)oxane-3,4,5-triol

C18H19NO8 (377.1111)


   

(2r,3s,4s,5s,6s)-2-(hydroxymethyl)-6-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)oxane-3,4,5-triol

(2r,3s,4s,5s,6s)-2-(hydroxymethyl)-6-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)oxane-3,4,5-triol

C18H19NO8 (377.1111)


   

4-[5-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1h-imidazol-4-yl]pyridine

4-[5-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1h-imidazol-4-yl]pyridine

C21H16FN3OS (377.0998)